Molecular Basis of Hyperlipidemias: Lessons from the Finnish Gene Inheritage

References

• Academy of Finland, Medical Research Council: Consensus Development Conference Statement. Blood cholesterol and coronary heart disease. Ann Med 1989; 21: 415–24
   PubMedGoogle Scholar
• Pyörälä K, Salonen J T., Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology 1985; 72: 35–51
   PubMed Web of Science ®Google Scholar
• Grundy S M., Wilhelmsen L, Rose G, Campbell R WF, Assman G. Coronary heart disease in high-risk populations: lessons from Finland. EurHeart J 1990; 11: 462–71
   Google Scholar
• Nevanlinna H R. The Finnish population structure. A genetic and genealogical study. Hereditas 1972; 71: 195–236
   PubMed Web of Science ®Google Scholar
• Norio R, Nevanlinna H R., Perheentupa J. Hereditary diseases in Finland: rare flora in rare soil. Ann Clin Res 1973; 5: 109–41
   PubMedGoogle Scholar
• Nissinen A, Piha T, Tuomilehto J, Romo M, Puska P. Comparison of the levels of cardiovascular risk factors between eastern and south-western Finland in 1982. Acta Med Scand 1987; 222: 389–400
   PubMedGoogle Scholar
• Breslow J L. Human apolipoprotein molecular biology and genetic variation. Ann Rev Biochem 1985; 54: 699–727
   PubMed Web of Science ®Google Scholar
• Brown M S., Goldstein J L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47
   PubMed Web of Science ®Google Scholar
• Kontula K, Aalto-Setälä K, Nikkilä E. DNA, hyperlipidemias and atherosclerosis. Ann Clin Res 1986; 18: 242–9
   PubMedGoogle Scholar
• Lusis A J. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 1988; 29: 397–429
   PubMed Web of Science ®Google Scholar
• Humphries S E. DNA polymorphisms of the apolipoprotein genes—their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 1988; 72: 89–108
   PubMedGoogle Scholar
• Goldstein J L., Brown M S. Familial hypercholesterolemia. The metabolic basis of inherited diseases, J B. Stanbury, J B. Wyngaarden, D S. Fredrickson, J L. Goldstein, M S. Brown. McGraw-Hill, New York 1983; 672–712
   Google Scholar
• Russell D W., Esser V, Hobbs H. Molecular basis of familial hypercholesterolemia. Arteriosclerosis 1989; 9(suppl 1)1–8–1–13
   Google Scholar
• Aalto-Setälä K, Gylling H, Miettinen T, Kontula K. Identification of a deletion in the LDL receptor gene. A Finnish type of mutation. FEBS Lett 1988; 230: 31–4
   PubMedGoogle Scholar
• Aalto-Setälä K, Helve E, Kovanen P, Kontula K. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalizationdefective phenotype. J Clin Invest 1989; 84: 499–505
   PubMed Web of Science ®Google Scholar
• Soria L F., Ludwig E H., Clarke H R., Vega G L., Grundy S M., McCarthy B J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 1989; 86: 587–1
   PubMed Web of Science ®Google Scholar
• Tybjærg-Hansen A, Gallagher J, Vincent J, et al. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis 1990; 80: 235–42
   PubMedGoogle Scholar
• Hämäläinen T, Palotie A, Aalto-Setälä K, Kontula K, Tikkanen M. Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol. Atherosclerosis 1990; 82: 177–83
   PubMedGoogle Scholar
• Aalto-Setälä K, Tikkanen M, Taskinen M-R, Nieminen M, Holmberg P, Kontula K. Xbal and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis 1988; 74: 47–54
   PubMed Web of Science ®Google Scholar
• Aalto-Setälä K, Gylling H, Helve E, et al. Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet 1989; 82: 305–7
   PubMed Web of Science ®Google Scholar
• Berg K. A new serum type system in man: the Lp-system. Acta Pathol Microbiol Scand 1963; 59: 369–82
   PubMedGoogle Scholar
• McLean J W., Tomlinson J E., Kuang W. J. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132–7
   PubMed Web of Science ®Google Scholar
• Miles L A., Fless G M., Levin E G., Scanu A M., Plow E F. A potential basis for the thrombotic risk associated with lipoprotein(a). Nature 1989; 339: 301–3
   PubMed Web of Science ®Google Scholar
• Hajjar K A., Gavish D, Breslow J L., Nachman R L. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303–5
   PubMed Web of Science ®Google Scholar
• Brown M S., Goldstein J L. Plasma lipoproteins: Teaching old dogmas new tricks. Nature 1989; 339: 113–4
   Google Scholar
• Frick M H., Dahlen G, Furberg C, Ericson C, Wiljasalo M. Serum pre-β-1 lipoprotein fraction in coronary atherosclerosis. Acta Med Scand 1974; 195: 337–40
   PubMedGoogle Scholar
• Frick M H., Dahlen G, Berg K, Valle M, Hekali P. Serum lipids in angiographically assessed coronary atherosclerosis. Chest 1978; 73: 62–5
   PubMedGoogle Scholar
• Utermann G, Menzel H J., Kraft H G., Duba H C., Kemmler H G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458–65
   PubMed Web of Science ®Google Scholar
• Mahley R W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–30
   PubMed Web of Science ®Google Scholar
• Utermann G, Kindemann I, Kaffarnik H, Steinmetz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984; 65: 232–6
   PubMedGoogle Scholar
• Sing C F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein levels. Am J Hum Genet 1985; 37: 268–5
   PubMed Web of Science ®Google Scholar
• Kesäniemi Y A., Ehnholm C, Miettinen T A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80: 578–81
   PubMed Web of Science ®Google Scholar
• Gylling H, Kuusi T, Vanhanen H, Miettinen T. Apolipoprotein E phenotype and cholesterol metabolism in familial hypercholesterolemia. Atherosclerosis 1989; 80: 27–32
   PubMed Web of Science ®Google Scholar
• Menzel H-J, Kladetzky R. G., Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983; 3: 310–5
   PubMedGoogle Scholar
• Davignon J, Gregg R E., Sing C F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21
   PubMedGoogle Scholar
• Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lip Res 1986; 27: 227–35
   PubMed Web of Science ®Google Scholar
• Kuusi T, Nieminen M S., Ehnholm C, et al. Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989; 9: 237–41
   PubMedGoogle Scholar
• Miettinen T A., Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 1988; ii: 1261
   Google Scholar
• Tikkanen M J., Huttunen J K., Ehnholm C, Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990; 10: 285–8
   PubMedGoogle Scholar
• Lehtimäki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487–95
   PubMed Web of Science ®Google Scholar
• Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow J L. Hypertriglyceridemia as a result of human apo Clll gene expression in transgenic mice. Science 1990; 249: 790–3
   PubMed Web of Science ®Google Scholar
• Aalto-Setälä K, Kontula K, Sane T, Nieminen M, Nikkilä E. DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis 1987; 66: 145–52
   PubMedGoogle Scholar